India's Vision for Drug Safety and Innovation Showcased at Global Conclave
During the opening session of the First Global Drug Regulatory Conclave 2026, senior officials presented a comprehensive roadmap for enhancing drug safety, accelerating medical innovation and reinforcing quality assurance across borders.
Key messages included the need for a transparent, evidence‑driven regulatory framework that can keep pace with rapid technological change. The ministry outlined ongoing reforms such as digitizing approval processes, adopting risk‑based assessments and harmonizing standards with international best practices.
Delegates from multiple continents were invited to discuss mechanisms for information exchange, joint risk assessments and collaborative research. The overarching goal is to ensure that breakthrough therapies reach patients quickly without compromising safety or affordability.